Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Long-term outcome study of growth factor-treated pressure ulcers.

Payne WG, Ochs DE, Meltzer DD, Hill DP, Mannari RJ, Robson LE, Robson MC.

Am J Surg. 2001 Jan;181(1):81-6.

PMID:
11248182
2.

Sequential cytokine therapy for pressure ulcers: clinical and mechanistic response.

Robson MC, Hill DP, Smith PD, Wang X, Meyer-Siegler K, Ko F, VandeBerg JS, Payne WG, Ochs D, Robson LE.

Ann Surg. 2000 Apr;231(4):600-11.

3.

Safety and effect of transforming growth factor-beta(2) for treatment of venous stasis ulcers.

Robson MC, Phillip LG, Cooper DM, Lyle WG, Robson LE, Odom L, Hill DP, Hanham AF, Ksander GA.

Wound Repair Regen. 1995 Apr-Jun;3(2):157-67.

PMID:
17173644
4.

Safety and effect of topical recombinant human interleukin-1beta in the management of pressure sores.

Robson MC, Abdullah A, Burns BF, Phillips LG, Garrison L, Cowan W, Hill D, Vandeberg J, Robson LE, Scheeler S.

Wound Repair Regen. 1994 Jul;2(3):177-81.

PMID:
17156109
5.

Recombinant human platelet-derived growth factor-BB for the treatment of chronic pressure ulcers.

Robson MC, Phillips LG, Thomason A, Altrock BW, Pence PC, Heggers JP, Johnston AF, McHugh TP, Anthony MS, Robson LE, et al.

Ann Plast Surg. 1992 Sep;29(3):193-201.

PMID:
1524367
6.

Platelet-derived growth factor BB for the treatment of chronic pressure ulcers.

Robson MC, Phillips LG, Thomason A, Robson LE, Pierce GF.

Lancet. 1992 Jan 4;339(8784):23-5.

PMID:
1345953
7.

Effect of Tris, HEPES, and TES buffers on binding at mu-, delta-, and kappa-opioid sites in guinea pig brain.

Paterson SJ, Robson LE, Kosterlitz HW, Jin WQ.

J Pharmacol Methods. 1990 Jul;23(4):275-83.

PMID:
2164621
8.

Regional variations in binding capacities at mu-, delta- and kappa-opioid sites in membrane suspensions from rabbit brain.

Petrillo P, La Regina A, Sbacchi M, Tavani A, Robson LE, Kosterlitz HW.

Eur J Pharmacol. 1989 Jul 18;166(2):213-7.

PMID:
2551699
9.

High-performance liquid chromatography of the neuropeptides: the endogenous opioid peptides.

McKnight AT, Corbett AD, Paterson SJ, Robson LE, Kosterlitz HW.

Monogr Endocrinol. 1988;30:66-94. Review. No abstract available.

PMID:
3068528
10.

Modulation of binding at opioid receptors by mono- and divalent cations and by cholinergic compounds.

Kosterlitz HW, Paterson SJ, Robson LE.

J Recept Res. 1988;8(1-4):363-73. Review.

PMID:
2838622
11.
12.

Differential postnatal development of mu-, delta- and kappa-opioid binding sites in rat brain.

Petrillo P, Tavani A, Verotta D, Robson LE, Kosterlitz HW.

Brain Res. 1987 Jan;428(1):53-8.

PMID:
3815117
13.

Control by cations of opioid binding in guinea pig brain membranes.

Paterson SJ, Robson LE, Kosterlitz HW.

Proc Natl Acad Sci U S A. 1986 Aug;83(16):6216-20.

14.

Recent developments in bioassay using selective ligands and selective in vitro preparations.

Kosterlitz HW, Corbett AD, Gillan MG, McKnight AT, Paterson SJ, Robson LE.

NIDA Res Monogr. 1986;70:223-35. No abstract available.

PMID:
3020423
15.
16.

Differential postnatal development of mu-, delta-and chi-opioid binding sites in mouse brain.

Tavani A, Robson LE, Kosterlitz HW.

Brain Res. 1985 Dec;355(2):306-9.

PMID:
3002543
17.

Kappa-binding and degradation of [3H]dynorphin A (1-8) and [3H]dynorphin A (1-9) in suspensions of guinea pig brain membranes.

Gillan MG, Robson LE, McKnight AT, Kosterlitz HW.

J Neurochem. 1985 Oct;45(4):1034-42.

PMID:
2863329
18.

Pre-incubation of guinea-pig myenteric plexus with beta-funaltrexamine: discrepancy between binding assays and bioassays.

Corbett AD, Kostelitz HW, McKnight AT, Paterson SJ, Robson LE.

Br J Pharmacol. 1985 Jul;85(3):665-73.

19.

Species differences in the concentrations and distributions of opioid binding sites.

Robson LE, Gillan MG, Kosterlitz HW.

Eur J Pharmacol. 1985 May 28;112(1):65-71.

PMID:
2990966
20.

[3H]-Dynorphin A (1-8): degradation profile and binding characteristics in brain homogenates.

Gillan MG, Robson LE, McKnight AT, Kosterlitz HW.

Neuropeptides. 1985 Feb;5(4-6):533-6.

PMID:
2860610
21.

Recent developments in the bioassay of opioids.

Kosterlitz HW, Corbett AD, Gillan MG, McKnight AT, Paterson SJ, Robson LE.

Regul Pept Suppl. 1985;4:1-7. No abstract available.

PMID:
2997847
22.

Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor.

Corbett AD, Gillan MG, Kosterlitz HW, McKnight AT, Paterson SJ, Robson LE.

Br J Pharmacol. 1984 Sep;83(1):271-9.

23.

Opioid binding sites of the kappa-type in guinea-pig cerebellum.

Robson LE, Foote RW, Maurer R, Kosterlitz HW.

Neuroscience. 1984 Jun;12(2):621-7.

PMID:
6087201
24.

Radioligands for probing opioid receptors.

Paterson SJ, Corbett AD, Gillan MG, Kosterlitz HW, McKnight AT, Robson LE.

J Recept Res. 1984;4(1-6):143-54.

PMID:
6098650
25.

[3H]-dynorphin A (1-9): binding characteristics and degradation profile in brain homogenates.

Robson LE, Gillan MG, McKnight AT, Kosterlitz HW.

Life Sci. 1983;33 Suppl 1:283-6.

PMID:
6319878
26.

Classification of opioid receptors.

Paterson SJ, Robson LE, Kosterlitz HW.

Br Med Bull. 1983 Jan;39(1):31-6. Review. No abstract available.

PMID:
6301606
27.

The role of interaction between opiate receptors and alpha-adrenergic receptors in tolerance and dependence.

Robson LE, Mucha RF, Kosterlitz HW.

Biochem Soc Trans. 1983 Jan;11(1):64-5. No abstract available.

PMID:
6298026
28.

Interaction of p-nitrophenylalanine enkephalins with mu-, delta- and kappa-subtypes of the opiate receptor.

Fauchère JL, Do KQ, Schwyzer R, Robson LE, Gillan MG, Paterson SJ, Kosterlitz HW.

Eur J Pharmacol. 1982 Feb 5;77(4):339-42.

PMID:
6277677
29.

Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain.

Kosterlitz HW, Paterson SJ, Robson LE.

Br J Pharmacol. 1981 Aug;73(4):939-49.

30.

Specific protection of the binding sites of D-Ala2-D-Leu5-enkephalin (delta-receptors) and dihydromorphine (mu-receptors).

Robson LE, Kosterlitz HW.

Proc R Soc Lond B Biol Sci. 1979 Aug 31;205(1160):425-32.

PMID:
41257
32.

Biosynthesis of the enkephalins in the myenteric plexus of the guinea pig ileum: further analysis of the interaction of the enkephalins and their analogues with the opiate receptors.

Kosterlitz HW, McKnight AT, Corbett AD, Gillan MG, Paterson SJ, Robson LE, Sosa RP.

NIDA Res Monogr. 1979;27:48-53. No abstract available.

PMID:
232907
33.

The inhibitory effects of clonidine on the contractions of the guinea-pig ileum in the morphine-dependent and withdrawn states [proceedings].

Hughes J, Kosterlitz HW, Robson LE, Waterfield AA.

Br J Pharmacol. 1978 Mar;62(3):388P-389P. No abstract available.

Supplemental Content

Loading ...
Support Center